EXOZ vs MDBH

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 04, 2026

EXOZ

48.1
AI Score
VS
MDBH Wins

MDBH

48.4
AI Score

Investment Advisor Scores

EXOZ

48score
Recommendation
HOLD

MDBH

48score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric EXOZ MDBH Winner
Net Income -2.04M -6.74M EXOZ
Operating Income -1.80M 44,000 MDBH
ROE 530.4% -12.0% EXOZ
ROA -57.3% -11.7% MDBH
Total Assets 3.56M 57.46M MDBH
Cash 66,533 12.19M MDBH
Free Cash Flow -1.47M -2.97M EXOZ

Relative Price Performance (Last 90 Days)

EXOZ 1M: -43.1% · 3M: -53.3% MDBH 1M: +12.9% · 3M: -19.7%

Current Technical Phase

EXOZ

Markdown
Sell / avoid

Price below a falling SMA50 (slope -19.5%), weak momentum, RSI 29

RSI (14): 29.1 · Price: $4.63

MDBH

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 47

RSI (14): 47.0 · Price: $3.11

Fundamentals Snapshot

Metric EXOZ MDBH
Market Cap
Forward P/E 0.0 0.0
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% -0.9%
Gross Margin 1.0% 0.6%
Operating Margin 0.0% -124.6%
EPS -1.15 -2.12
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, MDBH is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.